Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Aditxt, Inc. (ADTX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Aditxt, Inc. (ADTX), most recent 12 months reported: revenue $14.34K, net loss $53.34M, free cash flow -$25.7M. Latest balance sheet on file: liquid cash $3.2M. From SEC filings. Others in Pharmaceutical Preparations: BioAdaptives Inc. · JUPITER NEUROSCIENCES, INC. · Skinvisible, Inc. · PRF Technologies Ltd. · GENELUX CORPORATION · Alaunos Therapeutics, Inc. · TALPHERA, INC. · AARDVARK THERAPEUTICS, INC.

Stock screener

Watchlist